Rare diseases
Investigational molecules
Locations
Back to Italy621 clinical trials in Meldola, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
ItalyEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
ItalyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
ItalyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
ItalyA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
ItalyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on blood cancers, including studies of novel therapeutic combinations for acute myeloid leukemia, multiple myeloma, and various lymphomas.
Studies are evaluating targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into advanced solid tumors, with particular emphasis on colorectal cancer, non-small cell lung cancer, and breast cancer.
Investigations focus on personalized treatment strategies and novel drug combinations.
Groundbreaking studies in urological cancers, including research on prostate cancer, urothelial cancer, and renal cell carcinoma.
Research aims to improve survival rates through innovative therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
